Active Studies

Showing 181-190 trials of 202 total

• Diabetes

  Dulce Digital 2.0

  This trial is currently enrolling

  Randomized controlled trial testing the efficacy of a text messaging intervention in a low income, low health literacy group of Latino patients. Project Dulce 2.0 (PD 2.0) will address barriers to participation in health education classes, increasing adherence to treatment and medications and ...

• Hepatology

  A Phase 3, Open-Label Study with Asunaprevir and Daclatasvir Plus Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) (P/R) (QUAD) for Subjects Who are Null or Partial Responders to Peginterferon Alfa-2a or 2b Plus Ribavirin with Chronic Hepatitis C Genotypes 1 or 4 Infection [AI447029]

  This trial is not currently enrolling

  The purpose of this study is to assess efficacy, as determined by the proportion of subjects with Sustained Virologic Response at Post-Treatment Week 12 (SVR12), defined as Hepatitis C virus (HCV) Ribonucleic acid (RNA) < Limit of quantitation (LOQ) at post-treatment Week 12.

• Hepatology

  A Phase 2, Multicenter, Dose-Ranging Study to Evaluate the Safety and Efficacy of VX-135 with Ribavirin in Treatment-Naïve Adult Subjects with Genotype 1 Chronic Hepatitis C (VX12-135-101)

  This trial is currently enrolling

  A Phase 2 study to evaluate the safety and efficacy of two different once daily doses VX-135 in combination with ribavirin in treatment-naïve subjects with chronic hepatitis C

• Ophthalmology

  A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X 0.024% Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension – APOLLO Study

  This trial is currently enrolling

  In participants with a diagnosis of open angle glaucoma (OAG) or ocular hypertension (OHT), the primary objective is to demonstrate that the mean IOP reduction after 3 months of treatment with BOL-303259-X once daily (QD) is non-inferior to timolol maleate 0.5% twice daily (BID). The secondary ...

• Cardiology and Vascular Diseases

  Intracoronary Brachytherapy for Recurrent Restenosis after Multiple Drug-Eluting Stents. SCRIPPS V

  This trial is currently enrolling

  This study is a prospective study of patients treated at Scripps Clinic with intracoronary brachytherapy for recurrent restenosis within drug eluting stents.

• Hepatology

  A Randomized, Open-Label, Multicenter Study of the Safety, Efficacy, and Tolerability of Combination Treatment of Setrobuvir, Danoprevir, Ritonavir, and Copegus with or without Mericitabine in HCV Genotype 1Infected Patients Who are Either Treatment Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment

  This trial is not currently enrolling

  This randomized, open-label, multicenter study will evaluate the safety , efficacy and tolerability of the combination treatment RO5466731, RO5190591, ritonavir and Copegus (ribavirin) with or without RO5024048 in patients with chronic hepatitis C genotype 1. In Part 1, treatment-naïve patients will ...

• Allergy, Asthma, Immunology

  Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort (HSC# 004789)

  This trial is currently enrolling

  The aim of this sub-study is to determine whether healthy individuals over 90 years of age possess immune cells that are involved in protection from chronic disease. The immune system is well known to produce anti-cancer and other immune cells, called antibodies that can be beneficial to our health. ...

• REducing 30-day ADMIssions in posT-discharge subjects (“READMIT-HF Study”)

  This trial is not currently enrolling

  The purpose of this study is to collect and assess physiologic data in patients for up to 12 weeks following their hospitalization for heart failure (HF). Changes in physiologic data are expected to correlate with 30 day readmission rates in this population.

• Integrative Medicine

  Patients Receiving Integrative Medicine Interventions Effectiveness Registry (PRIMIER)

  This trial is currently enrolling

  This registry will perform prospective surveillance of participants attending collaborating Integrative Medicine clinic sites for clinical services. All decisions about medication use, treatments, visit frequency, assessment of tolerance, and other aspects of patient management will be left to the ...

• Cancer|Dermatology

  Observational Trial of Treatment/Effectiveness Patterns in Advanced Basal Cell

  This trial is currently enrolling

  This multi-center, prospective, observational cohort study will evaluate the effectiveness, safety and utilization of treatments in patients with advanced basal cell carcinoma and basal cell carcinoma nevus syndrome.